ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,521Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 1171

$1.2M Total Retail Price of All Prescriptions

Rank: 32 out of 1171

1,361 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,361 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 1,361 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 22,520 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,293 977 S3 1 8
SIMVASTATIN 1,204 1,063 2 1
AMLODIPINE BESYLATE 974 866 3 2
OMEPRAZOLE 951 768 4 5
LEVOTHYROXINE SODIUM 780 653 5 4
METOPROLOL TARTRATE 774 675 6 11
FUROSEMIDE 742 633 7 6
LISINOPRIL 700 595 8 3
METFORMIN HCL 513 400 9 7
GABAPENTIN 493 385 10 16
GLIMEPIRIDE 448 373 11 34
HYDROCHLOROTHIAZIDE 438 369 12 9
AZITHROMYCIN 344 282 13 43
LOSARTAN POTASSIUM 341 276 14 14
TRAMADOL HCL 339 275 15 18
ZOLPIDEM TARTRATE 328 248 16 21
SERTRALINE HCL 294 248 17 23
WARFARIN SODIUM 292 222 18 12
ATENOLOL 284 263 19 15
TRAZODONE HCL 272 186 20 37
NEXIUM 255 168 21 25
POTASSIUM CHLORIDE 250 193 22 19
CLOPIDOGREL 250 207 22 35
CARVEDILOL 239 216 24 20
DONEPEZIL HCL 239 238 24 24
FLUTICASONE PROPIONATE 231 183 26 30
MELOXICAM 227 185 27 56
DIOVAN 224 170 28 32
ISOSORBIDE MONONITRATE ER 219 207 29 44
RANITIDINE HCL 210 185 30 38
ATORVASTATIN CALCIUM 209 176 31 10
IBUPROFEN 209 168 31 80
PANTOPRAZOLE SODIUM 204 188 33 29
PAROXETINE HCL 201 154 34 62
PREDNISONE 198 148 35 39
METOPROLOL SUCCINATE 189 165 36 17
PLAVIX 186 159 37 55
ALPRAZOLAM 183 155 38 184
CYCLOBENZAPRINE HCL 178 113 R 39 67
BENAZEPRIL HCL 173 159 40 83
ALENDRONATE SODIUM 172 159 41 33
DIGOXIN 168 157 42 68
RAMIPRIL 167 165 43 85
MIRTAZAPINE 163 158 44 50
PRAVASTATIN SODIUM 163 132 44 13
ESCITALOPRAM OXALATE 160 122 46 69
BISOPROLOL-HYDROCHLOROTHIAZIDE 158 158 47 166
QUINAPRIL HCL 156 147 48 156
AMOX TR-POTASSIUM CLAVULANATE 151 116 49 142
CITALOPRAM HBR 146 113 50 22
QUETIAPINE FUMARATE 139 122 51 54
ALLOPURINOL 137 113 52 31
AMLODIPINE BESYLATE-BENAZEPRIL 136 124 53 70
TAMSULOSIN HCL 135 132 54 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 132 110 55 109
HYDRALAZINE HCL 126 117 56 60
KLOR-CON M20 126 119 56 41
ESTRADIOL 120 81 R 58 284
METHADONE HCL 120 23 S2 58 144
VENLAFAXINE HCL ER 118 59 60 113
DILTIAZEM 24HR ER 114 92 61 112
FENTANYL 112 106 S2 62 89
JANUVIA 111 108 63 66
CLONIDINE HCL 111 99 63 45
CYMBALTA 110 88 65 64
DOXYCYCLINE HYCLATE 108 85 66 137
ENALAPRIL MALEATE 104 81 67 73
GLIPIZIDE 102 102 68 47
FLUOXETINE HCL 98 45 69 76
PREMARIN 98 70 R 69 237
SYNTHROID 97 94 71 48
NYSTATIN 96 66 72 128
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 79 72 26
LANTUS SOLOSTAR 93 65 74 90
COUMADIN 91 91 75 253
BACLOFEN 91 25 75 110
NAMENDA 90 89 77 42
OXYCODONE-ACETAMINOPHEN 87 59 S2 78 59
NAPROXEN 83 71 79 95
CIPROFLOXACIN HCL 83 73 79 61
BUSPIRONE HCL 77 75 81 129
OXYCODONE HCL-ACETAMINOPHEN 74 0 S2 82 99
ADVAIR DISKUS 73 47 83 51
DILTIAZEM 24HR CD 72 69 84 101
LANTUS 66 39 85 46
LOSARTAN-HYDROCHLOROTHIAZIDE 66 63 85 40
JANTOVEN 65 65 87 147
CRESTOR 64 59 88 27
DIOVAN HCT 63 59 89 65
CLOTRIMAZOLE-BETAMETHASONE 63 53 89 174
SPIRONOLACTONE 61 58 91 53
POLYETHYLENE GLYCOL 3350 61 55 91 72
NITROFURANTOIN MONO-MACRO 59 45 93 210
LEXAPRO 59 46 93 222
AGGRENOX 59 51 93 148
LOVASTATIN 58 57 96 36
NITROSTAT 58 46 96 180
BENICAR 58 58 96 181
MOMETASONE FUROATE 57 51 99 266
GEMFIBROZIL 56 56 100 117
BUPROPION HCL SR 56 50 100 224
SYMBICORT 55 38 102 178
VESICARE 55 53 102 203
TRICOR 55 51 102 140
PROAIR HFA 54 41 105 49
AMIODARONE HCL 53 41 106 192
PROPRANOLOL HCL 53 45 106 134
TRIAMTERENE-HCTZ 53 46 106 58
TERAZOSIN HCL 53 53 106 143
HUMULIN 70-30 52 22 110 183
INSULIN SYRINGE 52 31 110 71
ROPINIROLE HCL 51 40 112 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.